Dana-Farber Cancer Institute ( Site 0050)

Boston, Massachusetts 02215

1 studies enrolling now · 1 studies all time

What they study most

Breast Cancer, Breast Neoplasms

Studies at this site

• Study of Patritumab Deruxtecan With Other Anticancer Agents in Participants With HER2 Positive Breast Cancer That Has Spread and Cannot Be Surgically Removed (MK-1022-009) — Recruiting now